Vanguard Group Inc Sage Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,265,802 shares of SAGE stock, worth $28.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,265,802

Previous 5,077,288 35.68%

Holding current value

$28.3 Million

Previous $40.4 Million 26.21%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$6.38 - $9.3 $11.6 Million - $16.8 Million	-1,811,486 Reduced 35.68%	3,265,802 $29.8 Million
Q1 2025 May 09, 2025	BUY	$5.55 - $8.66 $1.33 Million - $2.07 Million	239,119 Added 4.94%	5,077,288 $40.4 Million
Q4 2024 Feb 11, 2025	SELL	$4.78 - $8.57 $4.41 Million - $7.9 Million	-922,280 Reduced 16.01%	4,838,169 $26.3 Million
Q3 2024 Nov 13, 2024	SELL	$7.02 - $13.08 $4.6 Million - $8.58 Million	-655,872 Reduced 10.22%	5,760,449 $41.5 Million
Q2 2024 Aug 13, 2024	BUY	$10.58 - $17.9 $7.04 Million - $11.9 Million	664,948 Added 11.56%	6,416,321 $69.7 Million
Q1 2024 May 10, 2024	BUY	$18.62 - $26.95 $8.04 Million - $11.6 Million	432,013 Added 8.12%	5,751,373 $108 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $1.9 Million - $2.48 Million	111,358 Added 2.14%	5,319,360 $115 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $2.94 Million - $8.6 Million	175,565 Added 3.49%	5,208,002 $107 Million
Q2 2023 Aug 14, 2023	BUY	$40.65 - $59.54 $2.14 Million - $3.14 Million	52,666 Added 1.06%	5,032,437 $237 Million
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $3.51 Million - $4.39 Million	94,219 Added 1.93%	4,979,771 $209 Million
Q4 2022 Feb 10, 2023	BUY	$32.2 - $43.61 $3.15 Million - $4.26 Million	97,687 Added 2.04%	4,885,552 $186 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $1.45 Million - $1.95 Million	45,026 Added 0.95%	4,787,865 $187 Million
Q2 2022 Aug 12, 2022	BUY	$27.52 - $37.99 $3.24 Million - $4.48 Million	117,836 Added 2.55%	4,742,839 $153 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $1.44 Million - $2.14 Million	46,762 Added 1.02%	4,625,003 $153 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $9.38 Million - $11.9 Million	-253,028 Reduced 5.24%	4,578,241 $195 Million
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $260,039 - $370,552	6,459 Added 0.13%	4,831,269 $214 Million
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $265 Million - $383 Million	4,824,810 New	4,824,810 $274 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

50.3M

Call Options Held

772K

Put Options Held

440K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $516M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sage Therapeutics, Inc. Transaction History